Market position TrialScope Disclose is a recognized leader in clinical trial transparency and disclosure compliance, with adoption by 16 of the top 20 global sponsors. This indicates strong brand credibility and a ready pipeline of enterprise customers in regulated ecosystems.

Expansion opportunity Since TrialScope Disclose is now part of Pharma Intelligence, there is potential cross-sell and upsell to Pharma Intelligence’ existing clientele and data assets, enabling integrated solutions across broader life sciences workflows.

Partnership leverage Longstanding partnerships, such as renewals with Boehringer Ingelheim and high-profile collaborations, demonstrate trust among large pharma sponsors and create openings for expanded services like enhanced data disclosure, patient engagement, and recruitment optimization.

Product cadence Recent platform iterations and a dedicated CCO appointment signal a maturing product strategy and readiness to pursue larger enterprise deals, including commitments around compliance, transparency, and patient-centric disclosures.

Growth indicators Revenue visibility in the multi-million range with a modest funding base suggests opportunity for strategic partnerships or channel partnerships to accelerate scale, particularly targeting mid to large CROs and sponsor networks seeking compliance excellence.